Pathology: breast cancer (BC); la/mBC - HR-positive - 2nd line (L2);
| breast cancer (BC) | la/mBC - HR-positive - 2nd line (L2) | |||
| Brown (AE37 plus GM-CSF vs GM-CSF), 2020 | Brown (GP2 plus GM-CSF vs GM-CSF), 2020 | Huang, 2020 | ||
| AE37 vaccine plus GM-CSF | 1 | T1 | ||
| GP2 vaccine plus GM-CSF | 1 | T1 | ||
| OBI-822/OBI-821 plus cyclophosphamide | 1 | T1 | ||
| GM-CSF | 0 | T0 | T0 | |
| chemotherapy | 0 | T0 | ||